Peptide Library Our weight management peptides target stubborn fat, regulate appetite, and improve energy balance
Compounded GLP-1 medications contain compounded formulations of the active ingredient as brand-name drugs but aren't identical products - formulation, inactive ingredients, and manufacturing processes differ
This will help to prevent side effects such as lipohypertrophy (skin thickening under the skin)
This evidence-based guide examines: The pharmacology and mechanism of GLP-1 receptor agonists Whether delayed gastric emptying affects nutrient absorption How sustained appetite suppression may alter micronutrient density Protein intake and lean mass preservation during rapid weight loss Nutrients of potential concern (iron, vitamin B12, folate, magnesium, calcium, vitamin D, fat-soluble vitamins, electrolytes and zinc) Clinical monitoring strategies and laboratory markers Dietary and supplementation considerations grounded in current evidence Current literature does not support the claim that GLP-1 medications universally cause micronutrient deficiencies
Why pulsatile GH release outperforms supraphysiological dosing Exogenous HGH raises circulating GH in a flat, non-pulsatile pattern that the body has not evolved to process
